erosive esophagitis
Showing 1 - 25 of 37
Non-erosive Reflux Disease, Erosive Esophagitis Trial in United States (BLI5100)
Enrolling by invitation
- Non-erosive Reflux Disease
- Erosive Esophagitis
-
Huntsville, Alabama
- +20 more
May 25, 2023
Erosive Esophagitis Trial in Worldwide (Nexium 20mg, Nexium 10mg)
Recruiting
- Erosive Esophagitis
- Nexium 20mg
- Nexium 10mg
-
Sacramento, California
- +43 more
Aug 10, 2022
Gastroesophageal Reflux Disease, GERD, Gastroesophageal Erosion Trial in Moscow (diet adherence, No diet adherence, Change in
Recruiting
- Gastroesophageal Reflux Disease
- +5 more
- diet adherence
- +5 more
-
Moscow, Russian FederationFederal State Budgetary Scientific Institution "Federal Research
Aug 1, 2022
Erosive Esophagitis Trial in Seoul (JP-1366 20mg, Esomeprazole 40mg)
Recruiting
- Erosive Esophagitis
- JP-1366 20mg
- Esomeprazole 40mg
-
Seoul, Korea, Republic ofAsan Medical Center and 26 hospitals
Jul 11, 2022
Erosive Esophagitis Trial in Seoul (DWP14012)
Recruiting
- Erosive Esophagitis
-
Seoul, Korea, Republic ofKonkuk University Medical Center
May 12, 2021
Erosive Esophagitis Trial in Seoul (YYD601 40mg, Nexium 40mg, Placebos)
Completed
- Erosive Esophagitis
- YYD601 40mg
- +2 more
-
Seoul, Korea, Republic ofKorea University Ansan Hospital
May 7, 2021
Erosive Esophagitis Trial in Seoul (DWP14012)
Unknown status
- Erosive Esophagitis
-
Seoul, Korea, Republic ofHanyang University Medical Center
Oct 28, 2020
Erosive Esophagitis Trial in Seoul (DWP14012 40mg, DWP14012 40mg , Esomeprazole 40mg)
Completed
- Erosive Esophagitis
- DWP14012 40mg
- +3 more
-
Seoul, Korea, Republic ofHanyang University Medical Center
Sep 1, 2020
Erosive Esophagitis Trial in Worldwide (Vonoprazan, Lansoprazole, Vonoprazan Placebo)
Erosive Esophagitis Trial in Worldwide (Vonoprazan, Lansoprazole, Vonoprazan Placebo)
Erosive Esophagitis Trial in China (Dexlansoprazole, Lansoprazole, Placebo)
Terminated
- Erosive Esophagitis
- Dexlansoprazole
- +2 more
-
Beijing, Beijing, China
- +24 more
Oct 11, 2018
Erosive Esophagitis Trial in Kaohsiung (Esomeprazole 40 mg)
Completed
- Erosive Esophagitis
- Esomeprazole 40 mg
-
Kaohsiung, TaiwanSeng-Kee Chuah
Nov 21, 2017
Gastro Esophageal Reflux, Barrett Esophagus, Erosive Esophagitis Trial in Richmond (Confocal endomicroscopy, Endoscopic
Unknown status
- Gastro Esophageal Reflux
- +2 more
- Confocal endomicroscopy
- +2 more
-
Richmond, VirginiaHunter Holmes McGuire VA Medical Center
Jan 11, 2018
Erosive Esophagitis Trial in Seoul (CJ-12420 100mg QD, Esomeprazole 40mg, CJ-12420 50mg QD)
Completed
- Erosive Esophagitis
- CJ-12420 100mg QD
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 11, 2017
To Learn How Bone Structure and Bone Mass Change After Long-term
Completed
- Barrett's Esophagus
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Mar 28, 2017
Proton Pump Inhibitor Responsive Eosinophilic Esophagitis EoE:
Completed
- Erosive Esophagitis
- Esophageal Barium Xray
-
Rochester, MinnesotaMayo Clinic
Mar 21, 2017
Erosive Esophagitis Trial in Chonju (CJ-12420 formulation 2, CJ-12420 formulation 1)
Completed
- Erosive Esophagitis
- CJ-12420 formulation 2
- CJ-12420 formulation 1
-
Chonju, Korea, Republic ofChonbuk National University Hospital
Dec 13, 2016
Erosive Esophagitis Trial in Seoul (CJ-12420 100 mg QD, Esomeprazole 40 mg QD)
Completed
- Erosive Esophagitis
- CJ-12420 100 mg QD
- Esomeprazole 40 mg QD
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 14, 2016
Gastroesophageal Reflux Disease, Erosive Esophagitis Trial in Worldwide (Dexlansoprazole, Placebo)
Completed
- Gastroesophageal Reflux Disease
- Erosive Esophagitis
- Dexlansoprazole
- Placebo
-
Huntsville, Alabama
- +60 more
May 8, 2015
Gastroesophageal Reflux Disease, Erosive Esophagitis, Heartburn Trial in Woburn (Dexlansoprazole)
Completed
- Gastroesophageal Reflux Disease
- +2 more
-
Woburn, Massachusetts(unnamed)
Feb 22, 2015